Terms: = Cervical cancer AND RBM15, Q96T37, 64783, ENSG00000162775, OTT, OTT1 AND Treatment
33 results:
1. Impact of the COVID-19 pandemic on brachytherapy and cancer patient outcomes: A systematic review.
Parikh S; Zhang Y; Sherwani Z; Kumar R; Ohri N; Jan I; Vergalasova I; Jabbour S; Hathout L
Brachytherapy; 2024; 23(2):141-148. PubMed ID: 38307787
[TBL] [Abstract] [Full Text] [Related]
2. External Beam Radiotherapy Interdigitated with High Dose Rate(HDR) Intracavitary Brachytherapy versus External Beam Radiotherapy followed by Sequential HDR Intracavitary Brachytherapy for Locally Advanced Carcinoma Cervix-Randomized Control Study.
Gupta IJ; Ghosh A; Yadav J; Tuteja JS; Gupta R; Srivastava K; Verma M; Gupta S; Srivastava S; Bhatt MLB
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3441-3445. PubMed ID: 37898849
[TBL] [Abstract] [Full Text] [Related]
3. Survival outcome and prognostic factors post inadvertent hysterectomy in carcinoma cervix treated with salvage chemo-radiation.
Mishra R; Pandey A; Mishra H; Singh S; Jain P; Singh TB; Mandal A; Singh PK
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12355-12364. PubMed ID: 37434094
[TBL] [Abstract] [Full Text] [Related]
4. Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
Chopra S; Mulani J; Mittal P; Singh M; Shinde A; Gurram L; Scaria L; Aravindakshan D; Kohle S; Rane P; Ghadi Y; Rath S; Ghosh J; Gulia S; Gupta S; Kinhikar R; Laskar S; Agarwal JP
Brachytherapy; 2023; 22(2):125-131. PubMed ID: 36585283
[TBL] [Abstract] [Full Text] [Related]
5. The tolerance to chemoradiation for cervical cancer patients: A comparative prospective study of rural versus urban population.
Somashekar MK; Gururajachar JM; Arul Ponni TR; Koushik KA; Alva RC
J Cancer Res Ther; 2022; 18(6):1513-1517. PubMed ID: 36412402
[TBL] [Abstract] [Full Text] [Related]
6. Dose-effect relationship between dose-volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center retrospective study.
Ke T; Wang J; Zhang N; Zhao H; Guo X; Zhao Z; Mao Z; Cheng G
Strahlenther Onkol; 2023 Feb; 199(2):131-140. PubMed ID: 36109399
[TBL] [Abstract] [Full Text] [Related]
7. Survival outcome of cervical cancer patients treated by image-guided brachytherapy: a 'real world' single center experience in Thailand from 2008 to 2018.
Tharavichitkul E; Jia-Mahasap B; Muangwong P; Chakrabandhu S; Klunklin P; Onchan W; Tippanya D; Nobnop W; Watcharawipha A; Kittidachanan K; Galalae RM; Chitapanarux I
J Radiat Res; 2022 Jul; 63(4):657-665. PubMed ID: 35719089
[TBL] [Abstract] [Full Text] [Related]
8. Nomogram Predicting Overall Survival in Patients With Locally Advanced cervical cancer Treated With Radiochemotherapy Including Image-Guided Brachytherapy: A Retro-EMBRACE Study.
Sturdza AE; Pötter R; Kossmeier M; Kirchheiner K; Mahantshetty U; Haie-Meder C; Lindegaard JC; Jurgenliemk-Schulz I; Tan LT; Hoskin P; van Limbergen E; Gillham C; Segedin B; Tharavichitkul E; Iturre EV; Fokdal LU; Polterauer S; Kirisits C; Tanderup K
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):168-177. PubMed ID: 33932530
[TBL] [Abstract] [Full Text] [Related]
9. MRI-guided brachytherapy for locally advanced cervical cancer: Program initiation, learning curve and dose delivery results in Kuopio University Hospital.
Jääskeläinen E; Kärkkäinen H; Palmgren JE; Tolmunen T; Kraav SL; Anttila M
Brachytherapy; 2021; 20(4):738-747. PubMed ID: 33781713
[TBL] [Abstract] [Full Text] [Related]
10. Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients.
Kusada T; Toita T; Ariga T; Kudaka W; Maemoto H; Makino W; Ishikawa K; Heianna J; Nagai Y; Aoki Y; Murayama S
Int J Clin Oncol; 2020 Nov; 25(11):1977-1984. PubMed ID: 32852648
[TBL] [Abstract] [Full Text] [Related]
11. Comparative study to evaluate dosimetric differences in patients of locally advanced carcinoma cervix undergoing intracavitary brachytherapy under two different anaesthesia techniques: an audit from a tertiary cancer centre in India.
Kumar D; Srinivasa GY; Gupta A; Rai B; Oinam AS; Bansal P; Ghoshal S
J Egypt Natl Canc Inst; 2019 Nov; 31(1):5. PubMed ID: 32372231
[TBL] [Abstract] [Full Text] [Related]
12. Interdigitated versus sequential high-dose-rate intracavitary brachytherapy with external beam radiotherapy in locally advanced carcinoma cervix.
Alam N; Akram M; Siddiqui SA; Hussain MAB
J Cancer Res Ther; 2019; 15(6):1254-1259. PubMed ID: 31898656
[TBL] [Abstract] [Full Text] [Related]
13. A retrospective audit of treatment pathway for women diagnosed with cervical cancer in the Auckland region 2012-2016.
Parinpanayagam S; Brooks S
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):144-150. PubMed ID: 31788962
[TBL] [Abstract] [Full Text] [Related]
14. Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 cc.
Wang C; Raince J; Swamy U; Park SJ; Zaide L; Mesko S; Demanes DJ; Kamrava M
Brachytherapy; 2018; 17(2):392-398. PubMed ID: 29128230
[TBL] [Abstract] [Full Text] [Related]
15. Adjuvant Chemoradiation Therapy for cervical cancer and Effect of Timing and Duration on treatment Outcome.
Jhawar S; Hathout L; Elshaikh MA; Beriwal S; Small W; Mahmoud O
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1132-1141. PubMed ID: 28721897
[TBL] [Abstract] [Full Text] [Related]
16. Impact of treatment time-related factors on prognoses and radiation proctitis after definitive chemoradiotherapy for cervical cancer.
Huang EY; Lin H; Wang CJ; Chanchien CC; Ou YC
Cancer Med; 2016 Sep; 5(9):2205-12. PubMed ID: 27416796
[TBL] [Abstract] [Full Text] [Related]
17. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
[TBL] [Abstract] [Full Text] [Related]
18. Extended field radiotherapy with or without chemotherapy in patients with cervical cancer and positive para-aortic lymph nodes: a single institution retrospective review.
Ng BH; Rozita A; Adlinda A; Lee WC; Wan Zamaniah W
Asian Pac J Cancer Prev; 2015; 16(9):3827-33. PubMed ID: 25987044
[TBL] [Abstract] [Full Text] [Related]
19. Definitive concurrent chemoradiotherapy in cervical cancer--a University of Malaya Medical Centre experience.
Zamaniah WI; Mastura MY; Phua CE; Adlinda A; Marniza S; Rozita AM
Asian Pac J Cancer Prev; 2014; 15(20):8987-92. PubMed ID: 25374241
[TBL] [Abstract] [Full Text] [Related]
20. Clinical results of external beam radiotherapy alone with a concomitant boost program or with conventional fractionation for cervical cancer patients who did not receive intracavitary brachytherapy.
Matsuura K; Okabe T; Fujita K; Tanimoto H; Akagi Y; Kagemoto M
J Radiat Res; 2012 Nov; 53(6):900-5. PubMed ID: 22859563
[TBL] [Abstract] [Full Text] [Related]
[Next]
